Serum LINC01133 combined with CEA and CA19-9 contributes to the diagnosis and survival prognosis of gastric cancer. [PDF]
Sui X, Zhang Q, Hao M, Chen Y.
europepmc +1 more source
Ruptured large hepatic cyst with elevated serum and ascites CA19-9 level. [PDF]
Mizukami R +15 more
europepmc +1 more source
Multi-omics-driven discovery of invasive patterns and treatment strategies in CA19-9 positive intrahepatic cholangiocarcinoma. [PDF]
Ma D +12 more
europepmc +1 more source
Serum CA19-9 and CEA levels, serum CAT, GSH, oxidised glutathione levels, 8-dihidro-2'-deoksiguanosina and F2-isoprostanes levels in colorectal cancer patients and Lactobacillus: A randomised double-blind controlled trial. [PDF]
Chen S +5 more
europepmc +1 more source
Exosomal CD40, CD25, and Serum CA19-9 as Combinatory Novel Liquid Biopsy Biomarker for the Diagnosis and Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. [PDF]
David P +14 more
europepmc +1 more source
Serum CA19-9 as a predictor of incident metabolic syndrome in obese middle-aged and older men: A 9-year cohort study. [PDF]
Yu CW, Wu LW, Hu JM, Chang PK.
europepmc +1 more source
A rigorous multi-laboratory study of known PDAC biomarkers identifies increased sensitivity and specificity over CA19-9 alone. [PDF]
Haab B +19 more
europepmc +1 more source
Laparoscopic partial splenectomy for a giant splenic pseudocyst with elevated CA19-9: a case report. [PDF]
Sun Y, Yu XF, Yao H, Chai C.
europepmc +1 more source

